EUVIMEDEUVIMED entdecken
Crossref

Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?

Catherine M Kelly, Lore Komanyane, Eleni Andreopoulou

Breast Cancer Management · 2017

DOI: 10.2217/bmt-2016-0025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Management, 2017. Verfasst von Catherine M Kelly und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kelly, C. M., Komanyane, L., & Andreopoulou, E. (2017). Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?. Breast Cancer Management. https://doi.org/10.2217/bmt-2016-0025

Vancouver

Kelly CM, Komanyane L, Andreopoulou E. Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?. Breast Cancer Management. 2017. doi:10.2217/bmt-2016-0025

BibTeX
@article{Kelly2017,
  author = {Kelly, Catherine M and Komanyane, Lore and Andreopoulou, Eleni},
  title = {Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?},
  journal = {Breast Cancer Management},
  year = {2017},
  doi = {10.2217/bmt-2016-0025}
}
Kostenlos starten →